VIQ Solutions Reports Third Quarter 2021 Financial Results
VIQ Solutions Inc. reported its financial results for Q3 2021, revealing a revenue of $7.1 million, down from $8.2 million in Q3 2020. The net loss increased to $3.9 million from $0.3 million in the prior year, impacted by reduced COVID-19 wage subsidies and higher operating costs. Gross profit was $3.6 million (51% margin) versus $4.9 million (60% margin) a year earlier. The company reiterated its revenue goal of $34-35 million for 2021, dependent on the Auscript acquisition closing by mid-November. For 2022, they anticipate revenue of at least $50 million with a gross margin of 47%-55%.
- Acquisition of TTA completed, enhancing service capabilities.
- Expectation of increased revenues from Auscript acquisition.
- Projected revenue growth of at least $50 million for 2022.
- Revenue dropped 13.4% year-over-year.
- Net loss increased significantly from $0.3 million to $3.9 million.
- Adjusted EBITDA swung to negative $3.1 million from positive $2.0 million.
Reconfirms Goals Dependent Upon Timing of Close of Auscript Acquisition
“Now that we have executed the majority of our major corporate initiatives this year to fortify our strong foundation, we are firmly positioned to accelerate disruption. Our focus is on executing our growth plan by investing in and enabling organic growth and accelerating the M&A transactions in the pipeline. This includes closing the Auscript acquisition in the fourth quarter, integrating our recent acquisitions and the continued improvement of our technology enabled productivity gains and expansion of our geographic footprint.” said
“We made meaningful progress this year in refining operations, driving significant improvements in services gross margin through the migration and deployment of NetScribe™ technology, and we continue to execute new and renewed contracts to drive organic growth and upsell opportunities as we add our new products to renewal contracts. We will begin to see the impact of FirstDraft in the overall competitive landscape and in margin attainment. As we track and report KPI’s next year and following the integration of the Auscript and TTA acquisitions, the positive impact on operations will become evident in our results,” said
Third Quarter 2021 Financial Highlights:
-
Revenue of
compares to$7.1 million in the same quarter of 2020. Approximately,$8.2 million of the decrease in revenue was due to slower recovery in$0.6 million the United States from COVID-19 resulting in lower transcription revenue mostly from media and criminal justice verticals and the extendedAustralia shutdown. The remaining decrease of of revenue is related to a one-time transcription project revenue recorded in 2020;$0.5 million -
Gross profit of
represented$3.6 million 51% of revenue compared to , or$4.9 million 60% of revenue, in the same quarter of 2020. In addition to revenue decline, the decrease in gross margin for the three months endedSeptember 30, 2021 , versus the same period of the prior year was primarily due a reduction in COVID-19 wage subsidies received and higher operating costs due to labor shortages in$1.1 million the United States . This was partially offset by improved efficiency gains following the transition to machine versus human first drafts through the use of NetScribe, powered by aiAssist™; -
Adjusted EBITDA was negative
versus the same quarter in the prior year Adjusted EBITDA of positive$3.1 million . In addition to the reduction in gross profit previously mentioned, the decrease in Adjusted EBITDA was driven by higher Selling and Administrative expenses in the quarter, which increased by$2.0 million primarily driven by higher merger and acquisition costs and fees relating to the Company’s TSX and Nasdaq listings. In addition, COVID-19 wage subsidies in the current year quarter were$2.6 million lower versus the comparative period in 2020. For a reconciliation of net loss to Adjusted EBITDA, refer to the table at the end of this press release; and$1.2 million -
Net loss was
versus net loss of$3.9 million in the same quarter in 2020. Net loss for the current period was offset by a$0.3 million gain on revaluation of derivative warrant liability that is remeasured at the end of each reporting period,$0.8 million foreign exchange gain and$0.5 million less in amortization recorded on intangible assets.$0.2 million
Nine Month 2021 Financial Highlights:
-
Revenue of
decreased$23.5 million 2% compared to in the comparable period of the prior year. A decrease of$24.0 million of revenue related to a one time transcription project revenue in 2020;$0.9 million -
Gross profit of
represented$11.6 million 49% of revenue versus or$13.2 million 55% for the same period in 2020. Gross profit for the first nine months of 2021 was negatively impacted by the effects of COVID-19 shutdowns including delayed revenue, and reduced COVID-19 subsidies of approximately ;$2.1 million -
Adjusted EBITDA was negative
compared to a positive$3.1 million for the same period in 2020. Adjusted EBITDA was negatively impacted by lower gross margins and$4.3 million in higher SG&A expenses primarily driven by higher merger and acquisition costs and fees relating to the TSX and Nasdaq listing. In addition, COVID-19 subsidies were$3.5 million lower versus the comparable prior year period. For a reconciliation of net loss to Adjusted EBITDA, please see the table at the end of this press release; and$2.3 million -
Net loss was
versus a net loss of$16.0 million for the same period in 2020. Approximately$8.0 million of the current period’s loss relates to non-cash stock-based compensation following shareholder approval of a new omnibus plan offset by$6.4 million in lower interest expenses and related costs due to conversion of the Company’s convertible note in 2020.$6 million
“Volumes, gross margins, and contract renewals are trending upward, and new contracts delayed due to COVID-19 are resuming. More than ever, customers are looking to accelerate their digital transformation in a post pandemic hybrid environment,” said
“Achieving our revenue goal in 2021 of at least
Reiterating Goals for Full Year 2021 and 2022:
VIQ reiterates from its
The Company’s goals for 2022 include a full year of normalized revenue for
Subsequent Events:
On
On
Conference Call Details
VIQ will host a conference call and webcast to discuss its second quarter 2021 results on
Investors may access a live webcast of the call on the Company’s website at www.viqsolutions.com/investors or by dialing 1-833-378-1030 (
For more information about VIQ, please visit viqsolutions.com.
About
Forward-looking Statements
Certain statements included in this press release constitute forward-looking statements or forward-looking information under applicable securities legislation. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes.
Forward-looking statements or information typically contain statements with words such as "anticipate", "believe", "expect", "plan", "intend", "estimate", "propose", "project" or similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements or information in this press release include, but are not limited to Company’s current focus, the contemplated impact of significant new and renewed contracts on the Company, the impact of tracking and reporting KPIs and the Auscript and TTA acquisitions on the Company, the full year 2021 outlook, revenue goals for 2021 and 2022 and the benefits of the TTA acquisition on the Company.
Forward-looking statements or information is based on several factors and assumptions which have been used to develop such statements and information, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding, among other things, recent initiatives and that sales and prospects may provide incremental value for shareholders. Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions that have been used.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those express or implied by such forward-looking information, included but not limited to the factors described in greater detail in the “Risk Factors” section of the Company’s base shelf prospectus dated
These factors are not intended to represent a complete list of the factors that could affect the Company, however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
|
||||||
Interim Condensed Consolidated Statements of Financial Position |
||||||
(Expressed in |
||||||
|
|
|
||||
Assets |
|
|||||
Current assets |
|
|||||
Cash |
$ |
26,024,604 |
$ |
16,835,671 |
||
Trade and other receivables, net of allowance for doubtful accounts |
|
4,991,503 |
|
4,475,751 |
||
Inventories |
|
60,565 |
|
49,381 |
||
Prepaid expenses and deposits |
|
1,889,614 |
|
254,230 |
||
|
|
32,966,286 |
|
21,615,033 |
||
Non-current assets |
|
|||||
Restricted cash |
|
88,796 |
|
42,835 |
||
Property and equipment |
|
181,508 |
|
215,835 |
||
Right of use assets |
|
207,839 |
|
309,566 |
||
Intangible assets |
|
10,496,970 |
|
12,118,352 |
||
|
|
6,934,842 |
|
6,976,096 |
||
Deferred tax assets |
|
415,539 |
|
1,441,942 |
||
Total assets |
$ |
51,291,780 |
$ |
42,719,659 |
||
|
||||||
Liabilities |
|
|||||
Current liabilities |
|
|||||
Trade and other payables and accrued liabilities |
$ |
7,171,204 |
$ |
5,305,600 |
||
Income tax payable |
|
35,737 |
|
201,592 |
||
Share appreciation rights plan obligations |
|
– |
|
126,503 |
||
Share based payment liability |
|
376,340 |
|
– |
||
Derivative warrant liability |
|
2,452,332 |
|
– |
||
Current portion of long-term debt |
|
1,195,476 |
|
1,486,136 |
||
Current portion of lease obligations |
|
48,403 |
|
113,218 |
||
Current portion of contract liabilities |
|
991,448 |
|
1,252,957 |
||
|
|
12,270,940 |
|
8,486,006 |
||
Non-current liabilities |
|
|||||
Deferred tax liability |
|
60,301 |
|
60,587 |
||
Long-term debt |
|
12,026,552 |
|
12,138,799 |
||
Long-term contingent consideration |
|
842,392 |
|
1,575,528 |
||
Long-term lease obligations |
|
197,674 |
|
240,981 |
||
Long-term contract liabilities |
|
3,139 |
|
70,834 |
||
Other long-term liabilities |
|
421,710 |
|
360,525 |
||
Total liabilities |
|
25,822,708 |
|
22,933,260 |
||
|
||||||
Shareholders' Equity |
|
|||||
Capital stock |
|
72,273,856 |
|
50,234,551 |
||
Contributed surplus |
|
4,805,768 |
|
4,970,945 |
||
Accumulated other comprehensive loss |
|
(245,405) |
|
(78,906) |
||
Deficit |
|
(51,365,147) |
|
(35,340,191) |
||
Total liabilities and shareholders' equity |
$ |
51,291,780 |
$ |
42,719,659 |
||
|
||||||||||||
Interim Condensed Consolidated Statements of Loss and Comprehensive Loss |
||||||||||||
(Expressed in |
||||||||||||
Three months ended |
Nine Months ended |
|||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||
Revenue |
$ |
7,086,357 |
$ |
8,172,800 |
$ |
23,532,391 |
$ |
23,974,019 |
||||
Cost of Sales |
|
3,444,259 |
|
3,268,679 |
|
11,891,379 |
|
10,789,728 |
||||
Gross Profit |
|
3,642,098 |
|
4,904,121 |
|
11,641,012 |
|
13,184,291 |
||||
Expenses |
|
|
||||||||||
Selling and administrative expenses |
|
6,516,449 |
|
2,693,818 |
|
14,008,605 |
|
8,161,584 |
||||
Research and development expenses |
|
317,546 |
|
324,174 |
|
817,219 |
|
786,032 |
||||
Stock based compensation |
|
859,119 |
|
106,536 |
|
7,632,906 |
|
637,514 |
||||
Foreign exchange (gain) loss |
|
(445,978) |
|
21,709 |
|
(77,252) |
|
(285,191) |
||||
Depreciation |
|
45,736 |
|
144,290 |
|
189,392 |
|
347,363 |
||||
Amortization |
|
989,215 |
|
1,216,245 |
|
3,282,037 |
|
3,290,852 |
||||
|
|
8,282,087 |
|
4,506,772 |
|
25,852,907 |
|
12,938,154 |
||||
Income (loss) before undernoted items |
|
(4,639,989) |
|
397,349 |
|
(14,211,895) |
|
246,137 |
||||
|
|
|||||||||||
Operating income (loss) |
|
|
||||||||||
|
|
|||||||||||
Interest expense |
|
(329,598) |
|
(371,699) |
|
(996,611) |
|
(4,442,669) |
||||
Accretion and other financing costs |
|
(236,309) |
|
(317,192) |
|
(755,970) |
|
(881,752) |
||||
Gain (loss) on revaluation of conversion feature liability |
|
– |
|
16,407 |
|
– |
|
(1,175,145) |
||||
Loss on repayment of long-term debt |
|
– |
|
– |
|
– |
|
(1,290,147) |
||||
Gain on contingent consideration |
|
80,252 |
|
87,071 |
|
66,977 |
|
87,071 |
||||
Gain on revaluation of options |
|
501,974 |
|
– |
|
501,974 |
|
– |
||||
Gain on revaluation of RSUs |
|
119,012 |
|
– |
|
119,012 |
|
– |
||||
Gain on revaluation of the derivative warrant liability |
|
763,499 |
|
– |
|
763,499 |
|
– |
||||
Restructuring costs |
|
(35,072) |
|
– |
|
(395,324) |
|
– |
||||
Business acquisition costs |
|
(183,324) |
|
– |
|
(183,324) |
|
– |
||||
Other income |
|
2,226 |
|
583 |
|
10,520 |
|
688 |
||||
|
(3,957,329) |
|
(187,481) |
|
(15,081,142) |
|
(7,455,817) |
|||||
|
|
|||||||||||
Current income tax recovery (expense) |
|
42,562 |
|
(228,418) |
|
41,204 |
|
(672,693) |
||||
Deferred income tax recovery (expense) |
|
55,262 |
|
82,892 |
|
(985,018) |
|
82,892 |
||||
Income tax recovery (expense) |
|
97,824 |
|
(145,526) |
|
(943,814) |
|
(589,801) |
||||
Net loss for the period |
$ |
(3,859,505) |
$ |
(333,007) |
$ |
(16,024,956) |
$ |
(8,045,618) |
||||
|
|
|||||||||||
Net loss per share |
|
|
||||||||||
Basic |
|
(0.15) |
|
(0.02) |
|
(0.63) |
|
(0.46) |
||||
Diluted |
|
(0.15) |
|
(0.02) |
|
(0.63) |
|
(0.46) |
||||
Weighted average number of common shares outstanding - basic |
|
26,359,517 |
|
18,494,247 |
|
25,292,160 |
|
17,321,476 |
||||
Weighted average number of common shares outstanding - diluted |
|
26,359,517 |
|
18,494,247 |
|
25,292,160 |
|
17,321,476 |
||||
|
||||||||||||
|
||||||||
Consolidated Statements of Loss and Comprehensive Loss |
||||||||
(Expressed in |
||||||||
Reconciliation of Non-IFRS Measures |
||||||||
The following is a reconciliation of Net Loss to Adjusted EBITDA, the most directly comparable IFRS measure for the periods ended |
||||||||
Three months ended
|
|
Nine months ended
|
||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
||
Net Loss |
(3,859,505) |
(333,007) |
(16,024,956) |
(8,045,618) |
||||
Add: |
||||||||
Depreciation |
45,736 |
144,290 |
189,392 |
347,363 |
||||
Amortization |
989,215 |
1,216,245 |
3,282,037 |
3,290,852 |
||||
Interest expense |
329,598 |
371,699 |
996,611 |
4,442,669 |
||||
Current income tax recovery (expense) |
(42,562) |
228,418 |
(41,204) |
672,693 |
||||
Deferred income tax recovery (expense) |
(55,262) |
(82,892) |
985,018 |
(82,892) |
||||
EBITDA |
(2,592,780) |
1,544,753 |
|
(10,613,102) |
625,067 |
|||
Accretion and other financing expense |
236,309 |
317,192 |
755,970 |
881,752 |
||||
(Gain) Loss on revaluation of conversion feature liability |
- |
(16,407) |
- |
1,175,145 |
||||
Loss on repayment of long-term debt |
- |
- |
- |
1,290,147 |
||||
Gain on revaluation of options |
(501,974) |
- |
(501,974) |
- |
||||
Gain on revaluation of RSUs |
(119,012) |
- |
(119,012) |
- |
||||
Gain on revaluation of the derivative warrant liability |
(763,499) |
- |
(763,499) |
- |
||||
Restructuring Costs |
35,072 |
- |
395,324 |
- |
||||
Business acquisition costs |
183,324 |
- |
183,324 |
- |
||||
Other |
(2,226) |
(583) |
(10,520) |
(688) |
||||
Stock-based compensation |
859,119 |
106,536 |
7,632,906 |
637,514 |
||||
Foreign exchange (gain) loss |
(445,978) |
21,709 |
(77,252) |
(285,191) |
||||
Adjusted EBITDA |
(3,111,645) |
1,973,200 |
|
(3,117,835) |
4,323,746 |
|||
Non-IFRS Measures
Adjusted EBITDA is not a measure recognized by IFRS and does not have standardized meanings prescribed by IFRS. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that Adjusted EBITDA should not be construed as an alternative to net income (loss) as determined in accordance with IFRS.
The Company prepares its financial statements in accordance with IFRS. Non-IFRS measures are used by management to provide additional insight into our performance and financial condition. We believe non-IFRS measures are an important part of the financial reporting process and are useful in communicating information that complements and supplements the consolidated financial statements. This MD&A also includes certain measures which have not been prepared in accordance with IFRS such as Adjusted EBITDA. To evaluate the Company’s operating performance as a complement to results provided in accordance with IFRS, the term “Adjusted EBITDA” refers to net income (loss) before adjusting earnings for stock-based compensation, depreciation, amortization, interest expense, accretion and other financing expense, (gain) loss on revaluation of options, (gain) loss on revaluation of restricted share units, gain (loss) on revaluation of derivative warrant liability, restructuring costs, (gain) loss on revaluation of conversion feature liability, loss on repayment of long-term debt, business acquisition costs, impairment of goodwill and intangibles, other expense (income), foreign exchange (gain) loss, current and deferred income tax expense. We believe that the items excluded from Adjusted EBITDA are not connected to and do not represent the operating performance of the Company.
We believe that Adjusted EBITDA is useful supplemental information as it provides an indication of the results generated by the Company’s main business activities prior to taking into consideration how those activities are financed and taxed as well as expenses related to stock-based compensation, depreciation, amortization, impairment of goodwill and intangibles, other expense (income), and foreign exchange (gain) loss. Accordingly, we believe that this measure may also be useful to investors in enhancing their understanding of the Company’s operating performance.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006608/en/
Media:
Chief Marketing Officer
Phone: (800) 263-9947
Email: marketing@viqsolutions.com
Investor Relations:
High Touch Investor Relations
Phone: 1-914-598-7733
Email: viq@htir.net
Source:
FAQ
What were VIQ Solutions' earnings results for Q3 2021?
What is the revenue outlook for VIQ Solutions in 2021?
What is VIQ Solutions' future revenue goal for 2022?